CK156 是一种高度选择性的死亡相关蛋白激酶 (DAPK) 抑制剂,在 DRAK1 NanoBRET 试验中,DRAK1-IN-1 对 DRAK1,CK2a1,CK2a2 的IC50分别为 182 nM,34 μM,39 μM。CK156 可用于自身免疫和炎症性疾病的研究。
生物活性 | CK156 is a highly selectivedeath-associated protein kinase(DAPK) inhibitor withIC50s of 182 nM,34 μM, and 39 μM in the DRAK1 NanoBRET assay for DRAK1, CK2a1, and CK2a2, respectively. CK156 can be used for the research of autoimmune and inflammatory diseases[1]. |
分子量 | |
Formula | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |